
Velorum Therapeutics
Velorum Therapeutics is a YC Winter 2024 (W24) company. Based in San Francisco, CA, USA. Team of 5.
About Velorum Therapeutics
Summary
Velorum Therapeutics develops drugs that target heme biology, an area of disease mechanism that has seen little pharmaceutical attention. Heme dysregulation drives conditions including porphyrias, certain cancers, and organ injury from tissue damage, and Velorum builds therapies aimed at each of those disease contexts. The work replaces a gap in the existing drug landscape rather than a prior generation of treatments.
From the Y Combinator listing
Breakthrough medicines unlocking the biology of heme
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Facts
- Healthcare / Healthcare -> Therapeutics
- San Francisco, CA, USA
- 5
- Active
- Early
Founders (2)
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works